510(k) K071692

THERATEST EL-TTG IGA/IGG AND THERATEST EL-GLIA IGA/IGG TEST SYSTEMS by Theratest Laboratories, Inc. — Product Code MVM

K071692 is an FDA 510(k) premarket notification submitted by Theratest Laboratories, Inc. for the device "THERATEST EL-TTG IGA/IGG AND THERATEST EL-GLIA IGA/IGG TEST SYSTEMS". The FDA issued a decision of Substantially Equivalent on Nov 5, 2007. The device falls under product code MVM (Autoantibodies, Endomysial(Tissue Transglutaminase)), a Class II device regulated under 21 CFR 866.5660. Theratest Laboratories, Inc. has 21 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Nov 5, 2007
Date Received
Jun 20, 2007
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Autoantibodies, Endomysial(Tissue Transglutaminase)
Device Class
Class II
Regulation Number
866.5660
Review Panel
IM
Submission Type
510(k)

Need the full FDA record for Theratest Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K071692. Report a data issue: hello@regdatalab.com.